Kim Allen Eagle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kim Allen Eagle has a total of 655 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Bossone
Department of Public Health, University of Naples Federico II, Naples, Italy
9 shared publications - Debabrata Mukherjee
Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso
8 shared publications - Eric M. Isselbacher
Massachusetts General Hospital
8 shared publications - Eva Kline-Rogers
Division of Cardiovascular Medicine, Michigan Medicine, University of Michigan, Ann Arbor (Messrs Bryant, Graves, Barber, Weinstein, and Walden, Drs Rubenfire and Zhang, and Mss Katona, Fink, and Kline-Rogers); and Drexel University College of Medicine, Philadelphia, Pennsylvania (Mr Weinstein)
8 shared publications - Marion A. Hofmann Bowman
University of Michigan
8 shared publications - Himanshu Jagdish Patel
University of Michigan
7 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Acute aortic syndrome rule-out criteria: development and external validation
Background and Aims: Acute aortic syndrome (AAS) is a rare but catastrophic event, presenting with non-specific symptoms that mimic common conditions, and carries a mortality approaching 80% when missed. Current clinical tools, including the Aortic Dissection Detection Risk Score (ADD-RS) and its refinement, the simplified AORTA score, achieve high sensitivity when combined with D-dimer but fail to identify a population at sufficiently low risk to safely avoid further testing. To address this gap, the Acute Aortic Syndrome Rule-Out Criteria (ARC) were developed and validated, a pragmatic bedside tool designed to safely exclude AAS in low-risk patients without additional testing. Methods: A retrospective multistep derivation and validation study was conducted. The derivation cohort included patients with confirmed AAS from the International Registry of Acute Aortic Dissection (IRAD). Starting from existing scores, candidate predictors were identified from the IRAD dataset and sequentially added to achieve sensitivity ≥ 99%. External validation was performed in patients with suspected AAS across three prospective multicentre cohorts (ADvISED, PROFUNDUS, and DAShED). Diagnostic accuracy was assessed using sensitivity and specificity with 95% confidence intervals (CIs). Results: The final seven-variable ARC included age >60 years, abrupt onset pain, severe pain, hypotension/shock, neurological deficit, pulse deficit, and known aortic disease. Patients were classified as positive if any ARC variable was present and negative only if all variables were absent. In the derivation cohort, ARC achieved a sensitivity of 99.2% (95% CI 99.1–99.3). In the ADvISED/PROFUNDUS cohort (4598 patients, 10.2% AAS prevalence), sensitivity was 100% (95% CI 99.2–100) with specificity 23.7% (95% CI 22.4–25.0). In the DAShED cohort (5346 patients, 0.3% prevalence), sensitivity was 100% (95% CI 76.8–100) and specificity 36.4% (95% CI 35.1–37.7), ruling out 36.3% of patients without missing any AAS cases. Conclusions: ARC is an externally validated, pragmatic clinical rule demonstrating high diagnostic sensitivity in a large external validation cohort. When incorporated into existing diagnostic pathways, ARC has the potential to reduce unnecessary testing while maintaining diagnostic performance. Further prospective validation is required to confirm its clinical utility.
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Open AccessAcute aortic syndrome rule-out criteria: development and external validation
Background and Aims: Acute aortic syndrome (AAS) is a rare but catastrophic event, presenting with non-specific symptoms that mimic common conditions, and carries a mortality approaching 80% when missed. Current clinical tools, including the Aortic Dissection Detection Risk Score (ADD-RS) and its refinement, the simplified AORTA score, achieve high sensitivity when combined with D-dimer but fail to identify a population at sufficiently low risk to safely avoid further testing. To address this gap, the Acute Aortic Syndrome Rule-Out Criteria (ARC) were developed and validated, a pragmatic bedside tool designed to safely exclude AAS in low-risk patients without additional testing. Methods: A retrospective multistep derivation and validation study was conducted. The derivation cohort included patients with confirmed AAS from the International Registry of Acute Aortic Dissection (IRAD). Starting from existing scores, candidate predictors were identified from the IRAD dataset and sequentially added to achieve sensitivity ≥ 99%. External validation was performed in patients with suspected AAS across three prospective multicentre cohorts (ADvISED, PROFUNDUS, and DAShED). Diagnostic accuracy was assessed using sensitivity and specificity with 95% confidence intervals (CIs). Results: The final seven-variable ARC included age >60 years, abrupt onset pain, severe pain, hypotension/shock, neurological deficit, pulse deficit, and known aortic disease. Patients were classified as positive if any ARC variable was present and negative only if all variables were absent. In the derivation cohort, ARC achieved a sensitivity of 99.2% (95% CI 99.1–99.3). In the ADvISED/PROFUNDUS cohort (4598 patients, 10.2% AAS prevalence), sensitivity was 100% (95% CI 99.2–100) with specificity 23.7% (95% CI 22.4–25.0). In the DAShED cohort (5346 patients, 0.3% prevalence), sensitivity was 100% (95% CI 76.8–100) and specificity 36.4% (95% CI 35.1–37.7), ruling out 36.3% of patients without missing any AAS cases. Conclusions: ARC is an externally validated, pragmatic clinical rule demonstrating high diagnostic sensitivity in a large external validation cohort. When incorporated into existing diagnostic pathways, ARC has the potential to reduce unnecessary testing while maintaining diagnostic performance. Further prospective validation is required to confirm its clinical utility.
- 13 September 2026
- Published by Springer Nature
- p. 453-460
Perspective: Advances in the Management of Acute Aortic Syndrome
- 13 September 2026
- Published by Springer Nature
- p. 453-460
Perspective: Advances in the Management of Acute Aortic Syndrome
- 2 July 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (8) , e013292
Safety and Feasibility of Moderate-Intensity Home-Based Guided Exercise in Aortic Dissection Survivors in the United States: A Multicenter Randomized Controlled Trial
BACKGROUND: Survivors of aortic dissection frequently restrict personal physical activity due to concerns about provoking recurrent aortic events. We conducted a multicenter randomized controlled trial to evaluate the safety and feasibility of a moderate-intensity, home-based guided exercise (GE) regimen. METHODS: Between December 2022 and October 2024, adults ≥3 months post-Type A or B thoracic aortic dissection were randomized at 3 US academic medical centers to GE or usual care (UC; standardized exercise counseling and routine clinic visits). GE participants completed individualized training on a 6-exercise circuit and performed 12 months of home exercise with virtual follow-up visits. Coprimary outcomes were safety (aortic events, exertional hypertension, symptoms, injury, or events requiring medical care) and Patient-Reported Outcomes Measurement Information System 29-Item Profile scores. Secondary outcomes included exertional and ambulatory blood pressure and adherence. Continuous outcomes were compared using t or Mann-Whitney U tests; categorical using χ 2 or Fisher tests. RESULTS: Ninety-three participants (mean age, 56 years; 30% women; 67% Type A aortic dissection) were randomized to GE (n=44) or UC (n=49). Sixteen participants (5 GE and 11 UC) were lost to follow-up, and 65 participants completed all trial milestones. There were no deaths, aortic operations, or recurrent dissections in either group. Exertional hypertension during supervised training occurred in 17 (39%) GE participants and was mitigated by exercise modification. There were no significant changes in paired ambulatory blood pressure measurements (25 GE, 28 UC) or Patient-Reported Outcomes Measurement Information System 29-Item Profile scores (30 GE, 35 UC). CONCLUSIONS: In this pilot randomized trial, moderate-intensity home exercise appeared feasible and was not associated with observed excess aortic events compared with usual care. Larger prospective trials are needed to determine long-term effects on cardiovascular outcomes.
- 2 July 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (8) , e013292
Safety and Feasibility of Moderate-Intensity Home-Based Guided Exercise in Aortic Dissection Survivors in the United States: A Multicenter Randomized Controlled Trial
BACKGROUND: Survivors of aortic dissection frequently restrict personal physical activity due to concerns about provoking recurrent aortic events. We conducted a multicenter randomized controlled trial to evaluate the safety and feasibility of a moderate-intensity, home-based guided exercise (GE) regimen. METHODS: Between December 2022 and October 2024, adults ≥3 months post-Type A or B thoracic aortic dissection were randomized at 3 US academic medical centers to GE or usual care (UC; standardized exercise counseling and routine clinic visits). GE participants completed individualized training on a 6-exercise circuit and performed 12 months of home exercise with virtual follow-up visits. Coprimary outcomes were safety (aortic events, exertional hypertension, symptoms, injury, or events requiring medical care) and Patient-Reported Outcomes Measurement Information System 29-Item Profile scores. Secondary outcomes included exertional and ambulatory blood pressure and adherence. Continuous outcomes were compared using t or Mann-Whitney U tests; categorical using χ 2 or Fisher tests. RESULTS: Ninety-three participants (mean age, 56 years; 30% women; 67% Type A aortic dissection) were randomized to GE (n=44) or UC (n=49). Sixteen participants (5 GE and 11 UC) were lost to follow-up, and 65 participants completed all trial milestones. There were no deaths, aortic operations, or recurrent dissections in either group. Exertional hypertension during supervised training occurred in 17 (39%) GE participants and was mitigated by exercise modification. There were no significant changes in paired ambulatory blood pressure measurements (25 GE, 28 UC) or Patient-Reported Outcomes Measurement Information System 29-Item Profile scores (30 GE, 35 UC). CONCLUSIONS: In this pilot randomized trial, moderate-intensity home exercise appeared feasible and was not associated with observed excess aortic events compared with usual care. Larger prospective trials are needed to determine long-term effects on cardiovascular outcomes.
- 2 May 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (3) , 571-584.e1
Nonsyndromic familial type B aortic dissection exhibits distinct clinical profiles and operative outcomes
- 2 May 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (3) , 571-584.e1
Nonsyndromic familial type B aortic dissection exhibits distinct clinical profiles and operative outcomes
- Top Cited Papers
- 7 April 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (14) , 1060-1076
Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve
BACKGROUND: Bicuspid aortic valve (BAV) is a frequent congenital heart defect with a high heritability. Despite this, only a limited number of genes have been associated with the disease, and the molecular mechanisms remain unexplained in most cases. This study aimed to further understand the genetic architecture of BAV. METHODS: A genome-wide association study meta-analysis including 9631 cases among 65 677 participants was performed. Genes were prioritized using transcriptomic analyses based on RNA sequencing in relevant tissues, including human fetal and adult aortic valves. The impact of the knockdown or knockout of 4 candidate genes on cardiac development was verified in zebrafish. A polygenic risk score was developed, its association with BAV was evaluated in an independent cohort, and its association with a wide range of phenotypes (n=976) was evaluated in UK Biobank (n=355 618 individuals). RESULTS: Thirty-six genomic loci were identified, including 32 that were not described previously. Among the prioritized genes, KANK2 and ERBB4 were identified as potentially causal through transcriptomic analyses, colocalization, and Mendelian randomization based on gene expression in human aortic valves (n=484), whereas PRDM6 and STRN were prioritized using similar analyses from aortic (n=326) and left ventricular tissues (n=326), respectively. Targeting 4 candidate genes ( WNT4 , LEF1 , STRN , and KANK2 ) in zebrafish led to disruption in cardiac development. A polygenic risk score was associated with an odds ratio of 2.07 (95% CI, 1.90–2.25; P =5.43×10 -62 ) per SD for BAV and significantly associated with thoracic aortic aneurysm and atrial fibrillation in UK Biobank. CONCLUSIONS: This study supports a significant polygenic contribution to BAV, where the combination of multiple common variants in genes involved in heart morphogenesis disrupts aortic valve development.
- 7 April 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (14) , 1060-1076
Top Cited PapersGenome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve
BACKGROUND: Bicuspid aortic valve (BAV) is a frequent congenital heart defect with a high heritability. Despite this, only a limited number of genes have been associated with the disease, and the molecular mechanisms remain unexplained in most cases. This study aimed to further understand the genetic architecture of BAV. METHODS: A genome-wide association study meta-analysis including 9631 cases among 65 677 participants was performed. Genes were prioritized using transcriptomic analyses based on RNA sequencing in relevant tissues, including human fetal and adult aortic valves. The impact of the knockdown or knockout of 4 candidate genes on cardiac development was verified in zebrafish. A polygenic risk score was developed, its association with BAV was evaluated in an independent cohort, and its association with a wide range of phenotypes (n=976) was evaluated in UK Biobank (n=355 618 individuals). RESULTS: Thirty-six genomic loci were identified, including 32 that were not described previously. Among the prioritized genes, KANK2 and ERBB4 were identified as potentially causal through transcriptomic analyses, colocalization, and Mendelian randomization based on gene expression in human aortic valves (n=484), whereas PRDM6 and STRN were prioritized using similar analyses from aortic (n=326) and left ventricular tissues (n=326), respectively. Targeting 4 candidate genes ( WNT4 , LEF1 , STRN , and KANK2 ) in zebrafish led to disruption in cardiac development. A polygenic risk score was associated with an odds ratio of 2.07 (95% CI, 1.90–2.25; P =5.43×10 -62 ) per SD for BAV and significantly associated with thoracic aortic aneurysm and atrial fibrillation in UK Biobank. CONCLUSIONS: This study supports a significant polygenic contribution to BAV, where the combination of multiple common variants in genes involved in heart morphogenesis disrupts aortic valve development.
- Open Access
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e037506
Sex‐Related Differences in Clinical Profile, Management, and Outcomes of Patients With Type A and B Acute Aortic Dissection: Observations From IRAD
Background: Available data about sex differences in patients with acute aortic dissection (AAD) are scant and conflicting. The aim of this study is to assess sex‐related differences in clinical characteristics, presentation, diagnostic findings, management, and outcomes among patients with type A (TA‐AAD) and type B AAD (TB‐AAD). Methods: Data about 11 586 patients enrolled in the IRAD (International Registry of Acute Aortic Dissection) from 1996 to 2022, were analyzed; 7819 (67.5%) experienced TA‐AAD and 3867 (33.0%) TB‐AAD. Men and women were compared with regard to diagnosis, treatment, and in‐hospital and long‐term survival. Results: One third of patients were women (TA‐AAD, 34.4%; and TB‐AAD, 34.5%). Women were older than men for both types of AAD. The median time from hospital admission to diagnosis was longer in women for both TA‐AAD and TB‐AAD ( P P P P P P =0.23). No difference in overall ( P =1), medical ( P =0.38), endovascular ( P =1), and surgical ( P =0.51) mortality rates was observed for TB‐AAD between men and women. After TA‐AAD, women showed lower 4‐year survival compared with men (81.4% versus 86.6%, P <0.001). Conclusions: The present study highlights important sex‐related differences in AAD; there is a need to design tailored aortic disease management programs to improve outcomes in women.
- 3 March 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (5) , e037506
Open AccessSex‐Related Differences in Clinical Profile, Management, and Outcomes of Patients With Type A and B Acute Aortic Dissection: Observations From IRAD
Background: Available data about sex differences in patients with acute aortic dissection (AAD) are scant and conflicting. The aim of this study is to assess sex‐related differences in clinical characteristics, presentation, diagnostic findings, management, and outcomes among patients with type A (TA‐AAD) and type B AAD (TB‐AAD). Methods: Data about 11 586 patients enrolled in the IRAD (International Registry of Acute Aortic Dissection) from 1996 to 2022, were analyzed; 7819 (67.5%) experienced TA‐AAD and 3867 (33.0%) TB‐AAD. Men and women were compared with regard to diagnosis, treatment, and in‐hospital and long‐term survival. Results: One third of patients were women (TA‐AAD, 34.4%; and TB‐AAD, 34.5%). Women were older than men for both types of AAD. The median time from hospital admission to diagnosis was longer in women for both TA‐AAD and TB‐AAD ( P P P P P P =0.23). No difference in overall ( P =1), medical ( P =0.38), endovascular ( P =1), and surgical ( P =0.51) mortality rates was observed for TB‐AAD between men and women. After TA‐AAD, women showed lower 4‐year survival compared with men (81.4% versus 86.6%, P <0.001). Conclusions: The present study highlights important sex‐related differences in AAD; there is a need to design tailored aortic disease management programs to improve outcomes in women.
- Open Access
- 21 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (5) , 1142-1144
Latent growth of the non-dilated descending thoracic aorta as a marker of genetic aortopathy
- 21 February 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (5) , 1142-1144
Open AccessLatent growth of the non-dilated descending thoracic aorta as a marker of genetic aortopathy
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e038821
Thoracic Aortic Aneurysm Growth Rates and Predicting Factors: A Systematic Review and Meta‐Analysis
Background: Thoracic aortic aneurysm (TAA) is an indolent, potentially fatal disease, which progresses at variable rates that are influenced by pathogenesis and patient characteristics. We conducted a systematic review and meta‐analysis to synthesize the current evidence on growth rate (GR) and predictive factors among patients with syndromic and nonsyndromic heritable thoracic aortic disease, bicuspid aortic valve, and sporadic TAA. Methods and Results: Online databases were searched for studies that reported aortic growth on adult patients with asymptomatic TAA. Pooled GRs were calculated for 3 different TAA groups: syndromic heritable thoracic aortic disease, bicuspid aortic valve, and sporadic TAA. The search yielded 6297 studies, of which 85 were included in the systematic review, and 55 in the meta‐analysis of growth rate (10 syndromic heritable thoracic aortic disease, 31 bicuspid aortic valve, and 34 sporadic subgroups). Mean observed TAA GR was 0.25 mm/y (95% CI, −0.18 to 0.68) in Turner syndrome, 0.45 mm/y (95% CI, 0.00–0.90) in Marfan syndrome, and 0.81 mm/y (95% CI, −0.46 to 2.08) in Loeys–Dietz syndrome. The mean observed GR in patients with bicuspid aortic valve before aortic valve surgery was 0.37 mm/y (95% CI, 0.29–0.46), compared with 0.18 mm/y (95% CI, 0.14–0.33) in postsurgical studies. Mean observed GR in sporadic ascending TAA was 0.33 mm/y (95% CI, 0.13–0.52) and 2.71 mm/y (95% CI, 0.53–4.88) in descending TAA. Conclusions: Considering all pathogeneses, ascending TAAs typically grow at 0.25 to 1 mm/y, and thus annual surveillance is likely too frequent to detect growth in most patients. Studies vary widely in populations, methodology, and outcomes, with few high‐quality longitudinal studies and no predictors of aortic GR.
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e038821
Open AccessThoracic Aortic Aneurysm Growth Rates and Predicting Factors: A Systematic Review and Meta‐Analysis
Background: Thoracic aortic aneurysm (TAA) is an indolent, potentially fatal disease, which progresses at variable rates that are influenced by pathogenesis and patient characteristics. We conducted a systematic review and meta‐analysis to synthesize the current evidence on growth rate (GR) and predictive factors among patients with syndromic and nonsyndromic heritable thoracic aortic disease, bicuspid aortic valve, and sporadic TAA. Methods and Results: Online databases were searched for studies that reported aortic growth on adult patients with asymptomatic TAA. Pooled GRs were calculated for 3 different TAA groups: syndromic heritable thoracic aortic disease, bicuspid aortic valve, and sporadic TAA. The search yielded 6297 studies, of which 85 were included in the systematic review, and 55 in the meta‐analysis of growth rate (10 syndromic heritable thoracic aortic disease, 31 bicuspid aortic valve, and 34 sporadic subgroups). Mean observed TAA GR was 0.25 mm/y (95% CI, −0.18 to 0.68) in Turner syndrome, 0.45 mm/y (95% CI, 0.00–0.90) in Marfan syndrome, and 0.81 mm/y (95% CI, −0.46 to 2.08) in Loeys–Dietz syndrome. The mean observed GR in patients with bicuspid aortic valve before aortic valve surgery was 0.37 mm/y (95% CI, 0.29–0.46), compared with 0.18 mm/y (95% CI, 0.14–0.33) in postsurgical studies. Mean observed GR in sporadic ascending TAA was 0.33 mm/y (95% CI, 0.13–0.52) and 2.71 mm/y (95% CI, 0.53–4.88) in descending TAA. Conclusions: Considering all pathogeneses, ascending TAAs typically grow at 0.25 to 1 mm/y, and thus annual surveillance is likely too frequent to detect growth in most patients. Studies vary widely in populations, methodology, and outcomes, with few high‐quality longitudinal studies and no predictors of aortic GR.
- Open Access
- 26 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (6) , e039179
Growth Rate Assessed by Vascular Deformation Mapping Predicts Type B Aortic Dissection in Marfan Syndrome
Background: Patients with Marfan syndrome (MFS) are at a high risk of type B aortic dissection (TBAD). Aortic growth and elongation have been suggested as risk factors for TBAD. Vascular deformation mapping is an image analysis technique for mapping 3‐dimensional aortic growth on routine computed tomography angiography (CTA) scans. We aimed to use vascular deformation mapping to examine the value of aortic growth rate in the descending thoracic aorta, among other imaging biomarkers, to identify the factors associated with risk of TBAD in MFS. Methods: Computed tomography angiography scans spanning 2004 to 2023 from adult patients with MFS with native descending thoracic aorta were analyzed by vascular deformation mapping. Other measurements included multilevel thoracoabdominal aortic diameters and the length of the descending thoracic aorta by centerline analysis. Results: Among the 105 patients with MFS analyzed, 63.8% were men, with median age of 40 (range, 18–73) years and a median surveillance interval of 5.3 (range, 2.0–18.3) years. During surveillance, 12 (11.4%) patients developed TBAD. Patients with TBAD had a higher radial growth rate (0.63 versus 0.23 mm/year; P P <0.001), on univariate and multivariable analysis, but predissection descending aortic diameter was not significantly different. Predictors of growth rate included younger age, higher baseline maximal diameter of the descending thoracic aorta, smoking history, and warfarin use. Conclusions: Radial growth and elongation rates of the descending thoracic aorta were independent predictors of TBAD occurrence in MFS. TBAD often occurred at nonaneurysmal diameters (<4.0 cm). These findings emphasize the role of growth over absolute diameter in risk stratification for TBAD in MFS.
- 26 February 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (6) , e039179
Open AccessGrowth Rate Assessed by Vascular Deformation Mapping Predicts Type B Aortic Dissection in Marfan Syndrome
Background: Patients with Marfan syndrome (MFS) are at a high risk of type B aortic dissection (TBAD). Aortic growth and elongation have been suggested as risk factors for TBAD. Vascular deformation mapping is an image analysis technique for mapping 3‐dimensional aortic growth on routine computed tomography angiography (CTA) scans. We aimed to use vascular deformation mapping to examine the value of aortic growth rate in the descending thoracic aorta, among other imaging biomarkers, to identify the factors associated with risk of TBAD in MFS. Methods: Computed tomography angiography scans spanning 2004 to 2023 from adult patients with MFS with native descending thoracic aorta were analyzed by vascular deformation mapping. Other measurements included multilevel thoracoabdominal aortic diameters and the length of the descending thoracic aorta by centerline analysis. Results: Among the 105 patients with MFS analyzed, 63.8% were men, with median age of 40 (range, 18–73) years and a median surveillance interval of 5.3 (range, 2.0–18.3) years. During surveillance, 12 (11.4%) patients developed TBAD. Patients with TBAD had a higher radial growth rate (0.63 versus 0.23 mm/year; P P <0.001), on univariate and multivariable analysis, but predissection descending aortic diameter was not significantly different. Predictors of growth rate included younger age, higher baseline maximal diameter of the descending thoracic aorta, smoking history, and warfarin use. Conclusions: Radial growth and elongation rates of the descending thoracic aorta were independent predictors of TBAD occurrence in MFS. TBAD often occurred at nonaneurysmal diameters (<4.0 cm). These findings emphasize the role of growth over absolute diameter in risk stratification for TBAD in MFS.